期刊
CURRENT PHARMACEUTICAL DESIGN
卷 21, 期 38, 页码 5501-5517出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612821666151002112824
关键词
Thapsigargin; mipsagargin; drug development; clinical trials; structure activity relationships; prostate specific antigen; prostate specific membrane antigen; prodrug; anti-angiogenesis
资金
- Danish Cancer Society
- GenSpera
- Danish Strategic Research Council
Thapsigargin was originally isolated from the roots of the Mediterranean umbelliferous plant Thapsia garganica in order to characterize the skin irritant principle. Characteristic chemical properties and semi-syntheses are reviewed. The biological activity was related to the subnanomolar affinity for the sarco/endoplasmic reticulum calcium ATPase. Prolonged inhibition of the pump afforded collapse of the calcium homeostasis and eventually apoptosis. Structure-activity relationships enabled design of an equipotent analogue containing a linker. Conjugation of the analogue containing the linker with peptides, which only are substrates for either prostate specific antigen (PSA) or prostate specific membrane antigen (PSMA) enabled design of prodrugs targeting a number of cancer diseases including prostate cancer (G115) and hepatocellular carcinoma (G202). Prodrug G202 has under the name of mipsagargin in phase II clinical trials shown promising properties against hepatocellular carcinoma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据